Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exelixis Inc (NASDAQ:EXEL)

4.20
Delayed Data
As of Feb 12
 0.00 / 0.00%
Today’s Change
2.16
Today|||52-Week Range
6.81
-25.53%
Year-to-Date

Today’s Trading

Previous close4.20
Today’s open4.33
Day’s range4.01 - 4.33
Volume4,811,432
Average volume (3 months)4,264,904
Market cap$954.3M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-3.76%
Earnings growth (this year)+38.70%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-19.87%
P/E ratioNM
Price/Sales11.14
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...+0.46+5.49%
NXTMNxStage Medical Inc-0.57-3.91%
ARIAARIAD Pharmaceutical...+0.24+5.36%
FGENFibroGen Inc+0.51+2.97%
Data as of 4:14pm ET, 02/12/2016

Financials

Next reporting dateFebruary 23, 2016
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$25.1M
Annual profit (last year)-$268.5M
Net profit margin-1,069.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers